Abstract:In most animals, the development of the immature oocyte into a fertilizable gamete, a process known as oocyte maturation, involves an arrest in the meiotic cell cycle while awaiting fertilization. Depending on the organism, this arrest can occur at the beginning of meiosis I, in metaphase of meiosis I, in metaphase of meiosis II, or, after the completion of meiosis altogether, in the pronuclear stage. In the case of the vertebrate oocyte, maturation begins at the G2/M-phase border of meiosis I, and the arrest at the end of oocyte maturation occurs at metaphase of meiosis II. In vertebrates, premature arrest during oocyte maturation, as well as parthenogenetic release from the meiosis II arrest, is often the cause of infertility (Winston et al. 1991; Levran et al. 2002). In addition to gaining insight into the process of infertility, elucidation of the mechanism of meiotic arrest may increase our understanding of embryonic development, the molecular signal transduction pathways that operate in cell division, and cell cycle controls that may be altered in cancer cells. Over 30 years ago, YoshioMasui and ClementMarkert (1971) published an historic paper describing cytoplasmic control over the behavior of nuclei of both meiotic and mitotic cells. This paper described an activity in the cytoplasm of eggs from the leopard frog Rana pipiens that was able to initiate oocyte maturation when injected into immature G2-arrested oocytes, an activity they termed maturation-promoting factor (MPF). In the same paper, Masui and Markert discovered that microinjection of the same egg cytoplasm into one blastomere of a two-cell embryo produced a cleavage arrest in the injected blastomere, whereas the uninjected blastomere continued to divide normally. They observed that the “mitotic apparatus” of the injected blastomere was “arrested at metaphase.” As a control, cytoplasm taken from immature oocytes or early embryos did not inhibit cleavage of the injected blastomere. This led to the supposition that a “specific cytoplasmic factor or factors is responsible for the inhibition of mitosis and cleavage. This hypothetical factor from the cytoplasm of maturing oocytes can be tentatively labeled ‘cytostatic factor.’” Accordingly, the arrest of vertebrate eggs in meiosis II has since been renamed cytostatic factor (CSF) arrest, and the terms mature oocyte, metaphase-arrested oocyte, meiosis II-arrested oocyte, and CSF-arrested oocyte are synonymous with the term unfertilized egg. CSF, by definition, does not describe a single molecule or protein, but rather an activity found in the egg. This cell division inhibitor must accumulate during oocyte maturation, must be capable of functioning in meiosis II, and must be inactivated on fertilization or parthenogenetic activation. Since 1971, numerous attempts have been made to identify CSF(s) in vertebrate eggs and to elucidate the molecular mechanism of the meiotic metaphase arrest. Much of the progress in our understanding of the biochemistry and cell biology of CSF arrest since then has come from studies using the denuded oocytes, embryos, and cell-free extracts of the South African clawed frog Xenopus laevis. Although not as extensively studied, the oocytes of higher vertebrates, such as mice, recapitulate most features of Xenopus oocyte maturation, and contain components of CSF activity homologous to those that have been identified in the Xenopus system (Masui 2000; Kubiak and Ciemerych 2001). To understand the genesis of CSF activity and the mechanism of its action, it is important to consider the biology and biochemistry of oocyte maturation.

Under arrest: cytostatic factor (CSF)-mediated metaphase arrest in vertebrate eggs.

Investigation of the Antiviral Mechanism of Curcumin Analog EF-24 against Siniperca cachuatsi Rhabdovirus

Siniperca chuatsi Rhabdovirus (SCRV)-Induced Key Pathways and Major Antiviral Genes in Fish Cells

Antiviral effects of natural small molecules on aquatic rhabdovirus by interfering with early viral replication

Schisandrin A: A sustainable antiviral and immunomodulatory agent against spring viraemia of carp virus in aquaculture

Therapeutic potential of phenylpropanoid-based small molecules as anti-SVCV agents in aquaculture

In vitro screening for compounds derived from traditional chinese medicines with antiviral activities against porcine reproductive and respiratory syndrome virus.

Synthetic Peptides Outside the Spike Protein Heptad Repeat Regions As Potent Inhibitors of Sars-Associated Coronavirus

Chinese herbal extracts with antiviral activity: evaluation, mechanisms, and potential for preventing PRV, PEDV and PRRSV infections

Synthesis and biological evaluation of novel coumarin derivatives in rhabdoviral clearance

Identification of mycobacterial species by PCR restriction enzyme analysis of the hsp65 gene—an Indian experience.

Combination therapy with Polygala tenuifolia Willd and Phellodendron chinense Schneid extracts provides effective protection against Micropterus Salmoides Rhabdovirus in largemouth bass

In vivo and in vitro, antiviral effects of two mixture of Chinese herbal drug active monomers against MSRV and LMBV in largemouth bass (Micropterus salmoides)

COINFECTION OF TWO SINIPERCA CHUATSI VIRUSES AND MORPHOLOGIC CHANGES OF THE INFECTED CELLS

Antiviral innovations in largemouth bass aquaculture: Unveiling the potential of arctigenin derivatives against Micropterus Salmoides rhabdovirus

In vitro and in vivo evaluation of antiviral activity of a phenylpropanoid derivative against spring viraemia of carp virus

Therapeutic efficacy of tylvalosin combined with Poria cocos polysaccharides against porcine reproductive and respiratory syndrome

Potential prospect of a therapeutic agent against spring viraemia of carp virus in aquaculture

Identification of New Compounds against PRRSV Infection by Directly Targeting CD163

In vitro and in vivo inhibition of a novel arctigenin derivative on aquatic rhabdovirus

IRF11 regulates positively type I IFN transcription and antiviral response in mandarin fish, Siniperca chuatsi